V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients

BACKGROUND: Anemia is common among end-stage renal disease (ESRD) patients who undergone hemodialysis. The total reduction of red blood cell (RBC) count is associated with poor prognosis in these patients. Although erythropoietin (EPO) has been used as an effective treatment for ESRD patients with a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Biomed Sci
Hlavní autoři: Wong, Henry Sung-Ching, Chang, Che-Mai, Kao, Chih-Chin, Hsu, Yu-Wen, Liu, Xiao, Chang, Wen-Chang, Wu, Mai-Szu, Chang, Wei-Chiao
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5504791/
https://ncbi.nlm.nih.gov/pubmed/28697735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-017-0349-5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky